These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 15383505)

  • 21. Prostaglandin-independent effects of aspirin on cell cycle and putrescine synthesis in human colon carcinoma cells.
    Eklou-Kalonji E; Andriamihaja M; Reinaud P; Mayeur C; Camous S; Robert V; Charpigny G; Blachier F
    Can J Physiol Pharmacol; 2003 May; 81(5):443-50. PubMed ID: 12774850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular targets of nitric-oxide-donating aspirin in cancer.
    Kashfi K; Rigas B
    Biochem Soc Trans; 2005 Aug; 33(Pt 4):701-4. PubMed ID: 16042578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aspirin and NSAIDs for breast cancer chemoprevention.
    Yiannakopoulou ECh
    Eur J Cancer Prev; 2015 Sep; 24(5):416-21. PubMed ID: 25380191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aspirin and other nonsteroidal anti-inflammatory drugs and breast cancer incidence in a large U.S. cohort.
    Jacobs EJ; Thun MJ; Connell CJ; Rodriguez C; Henley SJ; Feigelson HS; Patel AV; Flanders WD; Calle EE
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):261-4. PubMed ID: 15668504
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tamoxifen, raloxifene, and the prevention of breast cancer.
    Jordan VC; Morrow M
    Endocr Rev; 1999 Jun; 20(3):253-78. PubMed ID: 10368771
    [No Abstract]   [Full Text] [Related]  

  • 26. Nitric oxide-releasing nonsteroidal anti-inflammatory drugs (NSAIDs) alter the kinetics of human colon cancer cell lines more effectively than traditional NSAIDs: implications for colon cancer chemoprevention.
    Williams JL; Borgo S; Hasan I; Castillo E; Traganos F; Rigas B
    Cancer Res; 2001 Apr; 61(8):3285-9. PubMed ID: 11309281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phytoestrogen intake from foods, during adolescence and adulthood, and risk of breast cancer by estrogen and progesterone receptor tumor subgroup among Ontario women.
    Anderson LN; Cotterchio M; Boucher BA; Kreiger N
    Int J Cancer; 2013 Apr; 132(7):1683-92. PubMed ID: 22907507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-steroidal anti-inflammatory drugs in chemoprevention of breast and prostate cancer.
    Badawi AF; El-Sohemy A
    Med Hypotheses; 2001 Aug; 57(2):167-8. PubMed ID: 11461166
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aspirin, salicylates, and cancer.
    Elwood PC; Gallagher AM; Duthie GG; Mur LA; Morgan G
    Lancet; 2009 Apr; 373(9671):1301-9. PubMed ID: 19328542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular targets of aspirin and cancer prevention.
    Alfonso L; Ai G; Spitale RC; Bhat GJ
    Br J Cancer; 2014 Jul; 111(1):61-7. PubMed ID: 24874482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical evidence of the relationship between aspirin and breast cancer risk (review).
    Jacobo-Herrera NJ; Pérez-Plasencia C; Camacho-Zavala E; González GF; Urrutia EL; García-Castillo V; Zentella-Dehesa A
    Oncol Rep; 2014 Aug; 32(2):451. PubMed ID: 24927467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of regular aspirin use and breast cancer risk.
    Swede H; Mirand AL; Menezes RJ; Moysich KB
    Oncology; 2005; 68(1):40-7. PubMed ID: 15802928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New studies support case for bisphosphonates as possible chemopreventive agent.
    Schmidt C
    J Natl Cancer Inst; 2010 Apr; 102(7):453-5. PubMed ID: 20339136
    [No Abstract]   [Full Text] [Related]  

  • 34. New evidence that NSAIDs reduce breast cancer risk.
    Oncology (Williston Park); 1997 Jul; 11(7):1046. PubMed ID: 9251123
    [No Abstract]   [Full Text] [Related]  

  • 35. Use of nonsteroidal antiinflammatory drugs and risk of breast cancer: the Case-Control Surveillance Study revisited.
    Zhang Y; Coogan PF; Palmer JR; Strom BL; Rosenberg L
    Am J Epidemiol; 2005 Jul; 162(2):165-70. PubMed ID: 15972932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mimicking pregnancy to reduce breast cancer risk.
    Tuma R
    J Natl Cancer Inst; 2010 Apr; 102(8):517-8. PubMed ID: 20388876
    [No Abstract]   [Full Text] [Related]  

  • 37. Nonsteroidal anti-inflammatory drug use and breast cancer risk: a Danish cohort study.
    Friis S; Thomassen L; Sørensen HT; Tjønneland A; Overvad K; Cronin-Fenton DP; Vogel U; McLaughlin JK; Blot WJ; Olsen JH
    Eur J Cancer Prev; 2008 Apr; 17(2):88-96. PubMed ID: 18287865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Do nonsteroidal anti-inflammatory drugs prevent melanoma?
    Bard S; Kirsner RS
    J Invest Dermatol; 2011 Jul; 131(7):1394. PubMed ID: 21673704
    [No Abstract]   [Full Text] [Related]  

  • 39. Breast cancer and use of nonsteroidal anti-inflammatory drugs: a meta-analysis.
    Takkouche B; Regueira-Méndez C; Etminan M
    J Natl Cancer Inst; 2008 Oct; 100(20):1439-47. PubMed ID: 18840819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The association between mammographic density measures and aspirin or other NSAID use.
    Stone J; Willenberg L; Apicella C; Treloar S; Hopper J
    Breast Cancer Res Treat; 2012 Feb; 132(1):259-66. PubMed ID: 22037829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.